Altamira Therapeutics
CYTO
#8281
Rank
$3.62 M
Marketcap
🇧🇲 Bermuda
Country
$1.62
Share price
0.00%
Change (1 day)
97.56%
Change (1 year)
Categories
Altamira Therapeutics (CYTO) - P/B ratio
P/B ratio as of May 2024 : 0.4724
According to Altamira Therapeutics's latest financial reports the company has a price-to-book ratio of 0.4724.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Altamira Therapeutics - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.6423 | -201.94% |
| 2022-12-31 | -0.6300 | -133.4% |
| 2021-12-31 | 1.89 | 19.97% |
| 2020-12-31 | 1.57 | 46.61% |
| 2019-12-31 | 1.07 | -76.72% |
| 2018-12-31 | 4.61 | -137.61% |
| 2017-12-31 | -12.3 | -563.08% |
| 2016-12-31 | 2.65 | -28.57% |
| 2015-12-31 | 3.70 | 76.47% |
| 2014-12-31 | 2.10 | |
| 2013-12-31 | N/A |